Contamination of drinking-water by arsenic in Bangladesh: a public health emergency
Contamination de leau de boisson par de larsenic au Bangladesh : une urgence de santé publique
Contaminación del agua de bebida con arsénico en Bangladesh: una emergencia de salud pública
Allan H. SmithI; Elena O. LingasII; Mahfuzar RahmanIII
IProfessor of Epidemiology, 140 Warren Hall, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-7360, USA
IIDoctoral Research Student, School of Public Health, University of California, Berkeley, USA
IIIInternational Fellow, Public Health Sciences Division, International Centre for Diarrheal Disease Research in Bangladesh, Dhaka, Bangladesh; Division of Occupational and Environmental Medicine, Faculty of Health Sciences, Linköping University, Sweden
The contamination of groundwater by arsenic in Bangladesh is the largest poisoning of a population in history, with millions of people exposed. This paper describes the history of the discovery of arsenic in drinking-water in Bangladesh and recommends intervention strategies. Tube-wells were installed to provide pure water to prevent morbidity and mortality from gastrointestinal disease. The water from the millions of tube-wells that were installed was not tested for arsenic contamination. Studies in other countries where the population has had long-term exposure to arsenic in groundwater indicate that 1 in 10 people who drink water containing 500 µg of arsenic per litre may ultimately die from cancers caused by arsenic, including lung, bladder and skin cancers. The rapid allocation of funding and prompt expansion of current interventions to address this contamination should be facilitated. The fundamental intervention is the identification and provision of arsenic-free drinking water. Arsenic is rapidly excreted in urine, and for early or mild cases, no specific treatment is required. Community education and participation are essential to ensure that interventions are successful; these should be coupled with follow-up monitoring to confirm that exposure has ended. Taken together with the discovery of arsenic in groundwater in other countries, the experience in Bangladesh shows that groundwater sources throughout the world that are used for drinking-water should be tested for arsenic.
Keywords: Bangladesh; arsenic poisoning, prevention and control; arsenic poisoning, therapy; water pollution, chemical, prevention and control; water treatment; environmental monitoring
La contamination des nappes phréatiques par de larsenic au Bangladesh est à ce jour la plus grande intoxication dune population recensée au cours de lhistoire, des millions de personnes ayant été exposées à larsenic. Le présent article décrit la découverte au Bangladesh de cette contamination de leau de boisson par larsenic et recommande des stratégies dintervention. Au début des années 70, on a installé des puits tubés afin de fournir de l« eau pure » et de prévenir la morbidité et la mortalité dues aux maladies gastrointestinales. Leau véhiculée par les millions de puits tubés qui ont été installés na pas été testée pour y rechercher une contamination par larsenic, car on nétait pas conscients à lépoque des problèmes de contamination.
En 1998, une enquête réalisée par la British Geological Survey portant sur 41 districts a permis de recueillir 2022 échantillons deau dont 35% se sont avérés posséder des concentrations darsenic supérieures à 50 µg/l (la concentration maximum autorisée au Bangladesh) et 8,4% des concentrations supérieures à 300 µg/l. Compte tenu de la densité de la population dans ce pays en 1998, la British Geological Survey a estimé que le nombre de personnes exposées à des concentrations darsenic supérieures à 50 µg/l était denviron 21 millions. Il faudrait multiplier ce nombre à peu près par deux si lon adoptait la concentration maximum recommandée par lOMS, qui est de 10 µg/l.
Les effets sur la santé de lingestion deau contaminée par larsenic se manifestent lentement. Pour cette raison, il est important de recenser le nombre de sujets qui présenteront des maladies à lavenir du fait dune exposition passée et présente à larsenic, en plus de ceux qui souffrent actuellement des maladies dues à larsenic. La période de latence pour les lésions cutanées provoquées par larsenic (cest-à-dire le temps qui sécoule entre la première exposition et la manifestation de la maladie), en particulier pour les kératoses, est habituellement de lordre de 10 ans. Le temps de latence pour les cancers cutanés et internes est de plus de 20 ans après la première exposition. Les études effectuées dans dautres pays où la population a été exposée à long terme à de larsenic contenu dans les nappes phréatiques indiquent quune personne sur 10 qui boit de leau contenant 500 µg/l darsenic peut finalement décéder dun des cancers provoqués par cette substance, notamment dun cancer du poumon, de la vessie ou de la peau.
Lallocation rapide de fonds et lexpansion accélérée des interventions actuelles devraient permettre de répondre à cette urgence de santé publique. Si lon peut relativement simplement atténuer lexposition à larsenic en fournissant de leau exempte darsenic, la situation au Bangladesh est plus complexe du fait de la faiblesse de léconomie et de la nécessité de compter essentiellement sur laide extérieure pour résoudre les problèmes de santé publique. Il existe également dans ce pays des difficultés importantes au niveau des communications et du transport qui constituent des obstacles pour les programmes dintervention et déducation communautaires. Néanmoins, contrairement à des maladies comme le paludisme, le choléra et la tuberculose, qui exigent des réponses de santé publique plus complexes, la réponse à une contamination de leau des puits tubés est claire et nette fournir de leau exempte darsenic. Larsenic est rapidement excrété dans lurine et, pour les cas précoces ou bénins, aucun traitement spécifique nest nécessaire. Léducation et la participation des communautés sont indispensables pour que les interventions soient couronnées de succès et doivent être associées à un suivi des opérations pour confirmer que lexposition a cessé.
Si lon ignore quelle est létendue exacte du problème, cela nannule en rien la nécessité dune réponse urgente. Létendue du problème pourra être déterminée pendant quon y apporte une réponse. La santé de la population est menacée il nest pas question dattendre des enquêtes complémentaires. La découverte de nappes phréatiques contaminées par de larsenic en Argentine, au Chili, en Chine, aux Etats-Unis, en Inde, au Mexique, en Chine (province de Taïwan), en Thaïlande et, aujourdhui, au Bangladesh illustre bien le fait quil sagit là dun problème mondial. Il convient donc de faire une recherche darsenic dans toutes les nappes phréatiques du monde utilisées pour leau de boisson.
La contaminación del agua freática con arsénico en Bangladesh es, hasta la fecha, el mayor caso de envenenamiento de una población registrado en la historia: millones de personas han estado expuestas al arsénico. En este trabajo se describe el descubrimiento en Bangladesh de la contaminación del agua de bebida con arsénico y se recomiendan estrategias para la intervención. A principios de los años setenta se instalaron pozos entubados para abastecer de «agua pura» y prevenir la morbilidad y mortalidad debidas a las enfermedades gastrointestinales. No se analizó la posible contaminación con arsénico del agua de los millones de pozos entubados que se instalaron porque a la sazón no se tenía conciencia de ese problema.
En un estudio realizado en 1998 por el British Geological Survey en 41 distritos se tomaron 2022 muestras de agua; se comprobó que en el 35% de ellas las concentraciones de arsénico superaban los 50 µg/l (valor máximo autorizado en Bangladesh) y en un 8,4% se superaban los 300 µg/l. Sobre la base de la densidad de población de 1998, el British Geological Survey estimó que el número de personas expuestas en Bangladesh a concentraciones de arsénico superiores a los 50 µg/l era de unos 21 millones. Esa cifra prácticamente se duplicaría si se adoptara la concentración máxima de 10 µg/l recomendada por la OMS.
Los efectos en la salud de ingerir agua contaminada con arsénico se manifiestan lentamente. Por esa razón, es importante identificar la cifra de personas que en el futuro enfermarán como consecuencia de una exposición pasada y persistente al arsénico, además de la cifra de pacientes que ya han enfermado por esa causa. El periodo de latencia de las lesiones cutáneas provocadas por el arsénico (es decir, el tiempo transcurrido desde la primera exposición hasta la manifestación de la enfermedad), en particular de las queratosis, es por regla general de unos 10 años. El periodo de latencia de los cánceres de la piel e internos es de más de 20 años a partir del momento de la exposición. Los estudios realizados en otros países en los que la población ha estado expuesta largo tiempo a aguas freáticas contaminadas con arsénico indican que una de cada 10 personas que toman agua con 500 µg/l de arsénico pueden acabar muriendo de cánceres causados por el arsénico, en particular de cánceres de pulmón, vejiga y piel.
Para responder a esta emergencia de salud pública habría que facilitar una rápida asignación de fondos y la expansión inmediata de las intervenciones actuales. Aunque la exposición al arsénico puede mitigarse de forma relativamente sencilla sin más que suministrar agua exenta de arsénico, la situación en Bangladesh se ve complicada por la debilidad de la economía y por su gran dependencia de la ayuda externa para resolver los problemas de salud pública. Las importantes dificultades que obstaculizan las comunicaciones y el transporte dentro de Bangladesh entorpecen también los programas comunitarios de intervención y educación. No obstante, a diferencia de enfermedades como el paludismo, el cólera o la tuberculosis, que requieren respuestas de salud pública más complejas, la respuesta a la contaminación de los pozos de agua entubados es muy simple: suministrar agua sin arsénico. El arsénico se elimina rápidamente por la orina y, en los casos precoces o leves, no se precisa tratamiento específico. La educación y la participación comunitarias son esenciales para asegurar que las intervenciones tengan éxito, y deben ir acompañadas de un seguimiento que confirme el final de la exposición.
Se desconoce la magnitud exacta del problema, pero no por ello es menos necesaria una respuesta de emergencia. La envergadura se podrá determinar en el transcurso de la respuesta. La salud de la población está en riesgo: el socorro no puede esperar a que se realicen más estudios. El descubrimiento de que existen aguas freáticas contaminadas con arsénico en la Argentina, Chile, China, los Estados Unidos de América, la India, México, la República de China (Taiwán), Tailandia y, ahora, Bangladesh evidencia que se trata de un problema mundial. Habría que analizar la presencia de arsénico en todas las aguas subterráneas del mundo que se utilizan para el consumo.
Bangladesh is grappling with the largest mass poisoning of a population in history because groundwater used for drinking has been contaminated with naturally occurring inorganic arsenic. It is estimated that of the 125 million inhabitants of Bangladesh between 35 million and 77 million are at risk of drinking contaminated water (1, 2). The scale of this environmental disaster is greater than any seen before; it is beyond the accidents at Bhopal, India, in 1984, and Chernobyl, Ukraine, in 1986. This paper suggests guidelines for responding when a population is exposed to arsenic, and it is based on information from several visits to Bangladesh made by Allan H. Smith as a consultant for the World Health Organization between 1997 and 1998 (35).
In 1983, the first cases of arsenic-induced skin lesions were identified by K.C. Saha then at the Department of Dermatology, School of Tropical Medicine in Calcutta, India (6). The first patients seen were from West Bengal, but by 1987 several had already been identified who came from neighbouring Bangladesh. The characteristic skin lesions included pigmentation changes, mainly on the upper chest, arms and legs, and keratoses of the palms of the hands and soles of the feet (Fig. 1). After ruling out other causes, water sources used by the patients were analysed, and the diagnosis of arsenic-caused disease was confirmed. The primary drinking-water sources for the patients were tube-wells, which drew water from underground aquifers (Fig. 2) (6).
Tube-wells have been used in Bangladesh since the 1940s (7). However, the problem of arsenic-contaminated water has only recently come to light due to the increasing number of tube-wells used over the past 20 years and the subsequent increase in the number of individuals drinking from them. Historically, surface water sources in Bangladesh have been contaminated with microorganisms, causing a significant burden of disease and mortality. Infants and children suffered from acute gastrointestinal disease resulting from bacterial contamination of stagnant pond water. Consequently, during the 1970s the United Nations Childrens Fund (UNICEF) worked with the Department of Public Health Engineering to install tube-wells to provide what was presumably a safe source of drinking-water for the population. These wells consist of tubes that are 5 cm in diameter that are inserted into the ground at depths of usually less than 200 m. The tubes are then capped with a cast iron or steel hand pump. At the time the wells were installed, arsenic was not recognized as a problem in water supplies, and therefore standard water testing procedures did not include tests for arsenic (7).
During the 1980s, UNICEFs support for installing tube-wells decreased because the private sector was able to supply and install millions more of them (7). By 1997, UNICEF indicated in its country report for Bangladesh that it had surpassed its goal of providing 80% of the population by 2000 with access to safe drinking-water in the form of tube-wells, ring-wells and taps (8). Presently, three out of four tube-wells in Bangladesh are privately owned (7).
Extent of exposure in the population
In Bangladesh, arsenic contamination of water in tube-wells was confirmed in 1993 in the Nawabganj district (1). Further testing was done in the following years; this included investigations by the Department of Occupational and Environmental Health of the National Institute of Preventive and Social Medicine. Results from various laboratories were collated in a WHO country situation report in 1996 (9). The institutions that provided results included the Jadavpur University in Calcutta, India, the Bangladesh Atomic Energy Commission, the Department of Public Health Engineerings laboratories in the Khulna and Rajshahi districts, and the National Institute of Preventive and Social Medicine in Dhaka. Altogether, 400 measurements were presented in the report, although contamination in some wells was measured by more than one laboratory. In about half of the measurements concentrations were above 50 µg/l (9), which is clearly in excess of the maximum level recommended by WHO of 10 µg/l (10) and greater than the maximum level of 50 µg/l permitted in Bangladesh (7).
To raise awareness of the seriousness of the arsenic problem inWest Bengal and to draw attention to the need for studies in Bangladesh, a conference was convened in 1995 by D. Chakraborti and the School of Environmental Studies of Jadavpur University in Calcutta (11). In the years after the conference, the extent of the problem in Bangladesh has become clearer through additional surveys of the water and population, many of which were led by Chakraborti.
A study conducted in the Rajarampur village of the Nawabganj district, by the National Institute of Preventive and Social Medicine and the School of Environmental Studies, found that 29% of the 294 tube-wells tested had arsenic concentrations greater than 50 µg/l (12). Between September 1996 and June 1997, a survey was jointly conducted by Dhaka Community Hospital and the School of Environmental Studies. An examination of 265 wells in Samta village in the Jessore district found that about 91% of the wells had arsenic concentrations higher than 50 µg/l (13). In 1998, a British Geological Survey of 41 districts collected 2022 water samples 35% were found to have arsenic concentrations above 50 µg/l (Table 1) and 8.4% were above 300 µg/l (14). Based on population density measured in 1998, this group estimated that the number of people exposed to arsenic concentrations above 50 µg/l was about 21 million. This number would be approximately doubled if WHOs standard of 10 µg/l were adopted. Further studies conducted by the School of Environmental Studies and the Dhaka Community Hospital found that 59% of the 7800 groundwater samples had arsenic concentrations greater than 50 µg/l (15).
In 1997 a project designed to establish the extent of the problem in a sample population was authorized by the government of Bangladesh. Two hundred villages that had already been identified as having arsenic-contaminated tube-wells were surveyed by the Rapid Action Programme. These villages had a combined population of 469 424. About 62% of the 32 651 tube-wells sampled had concentrations greater than 100 µg/l (16).
Surveys of the effects on the populations health have occurred concurrently with the previous studies of groundwater contamination. From December 1996 to January 1997, a three-week survey was conducted by the Dhaka Community Hospital and the School of Environmental Studies. The survey team visited 18 affected districts. Of the 1630 adults and children examined, 57.5% of them had skin lesions due to arsenic poisoning (11). In another study, approximately one-third of the 7364 patients examined had skin lesions due to arsenic (17).
The population of the 42 affected districts was 76.9 million. These studies do not imply that the entire population is drinking contaminated water. A recent report from the World Bank has estimated that 20 million inhabitants of Bangladesh may be drinking arsenic-contaminated water (18).
In the 200 villages surveyed by the Rapid Action Programme, 1802 of 469 424 people were found to have arsenic-induced skin lesions. During the same period a more detailed study of four villages with arsenic-contaminated tube-wells was conducted, and 1481 adults were interviewed and examined (19) . Of these, 430 were found to have skin lesions.
The actual extent of the contamination and the number of people with skin diseases caused by arsenic might be many times higher than is currently estimated. For comparison, it has been estimated that in West Bengal the number of people exposed to arsenic is 1.5 million, and one estimate of the number of patients with arsenicosis exceeds 200 000 (20, 21). Since the estimate of those who may be drinking arsenic-contaminated water in Bangladesh is in the tens of millions, it is reasonable to expect that unless exposure ends the number of people with arsenicosis will eventually far exceed the number observed in West Bengal. Although all wells and all villagers have not been systematically tested and examined, this should not delay action. The evidence that has accumulated since 1997 has only confirmed that this is a public health threat of great magnitude (Box 1).
Long-term health effects of exposure
The health effects of ingesting arsenic-contaminated drinking-water appear slowly (Box 2). For this reason, a more important issue than the number of patients who currently have arsenic-caused diseases is the number who will develop these diseases in the future as a result of past and continuing exposure to arsenic. Large numbers of tube-wells were installed in Bangladesh approximately 5 to 20 years ago. If the population continues to drink arsenic-contaminated water, then a major increase in the number of cases of diseases caused by arsenic may be predicted.
The latency for arsenic-caused skin lesions (i.e., the time from first exposure to manifestation of disease), in particular keratoses, is typically about 10 years (22). In the 1997 consultancy, it was found that the youngest individuals with skin lesions caused by arsenic were about 10 years old. Other studies have shown that skin lesions also occur in children younger than 10 years (23). It was also found that in adults, exposures commenced approximately 10 years before they stated the skin lesions began to appear. In some instances, the apparent latency for the appearance of skin lesions from the time of first exposure to contaminated water from the tube-well currently in use was much shorter, but as no measurements were available for water from previously used tube-wells, a short latency from first exposure could not be inferred. However, latency that is shorter or longer than 10 years may occur, and the rapidity of the appearance of skin lesions appears to be dose dependent (22). Further studies of the latency and patterns of occurrence of skin lesions are needed and these will require careful interviewing of participants about their current and past exposures.
Skin cancer. Small numbers of cases of skin cancer have started to appear. Since the typical latency is more than 20 years after the beginning of exposure, the fact that only a small number have been found provides little reassurance about the future incidence of skin cancer. A study of a large population in Taiwan found a clear dose-response relationship between arsenic concentrations in drinking-water and the prevalence of skin cancer (24). In this study, the average concentration of arsenic in water was about 500 µg/l, and by age 60 more than 1 in 10 had developed skin cancer. The lifetime risk of developing skin cancer from the intake of 1 µg · kg body weight -1 · day -1 (roughly equivalent to 1 litre per day at concentrations of 50 µg/l) of arsenic in water ranges from 1 per 1000 to 2 per 1000 (25). Though large numbers of skin cancers have been reported in Taiwan, the future burden of arsenic-caused skin cancer in Bangladesh is uncertain. Differences in susceptibility between the populations of Taiwan and Bangladesh may exist that only time and further study will identify. However, as yet there is no evidence to indicate that the long-term risks of skin cancer would be any lower in Bangladesh than in Taiwan.
Mortality from internal cancers. In other countries, the main causes of death associated with chronic ingestion of arsenic in drinking-water are internal cancers; skin cancers are not usually fatal if treated appropriately. Dramatic increases in mortality from internal cancers have been reported in Taiwan (2628) and Chile (29). In Taiwan, populations exposed to high concentrations of arsenic in their drinking-water, containing an average of 800 µg/l of arsenic, had estimates of their relative risk of bladder cancer in the order of 3060 (27, 30). In Region II of northern Chile, 510% of all deaths occurring among those over the age of 30 were attributable to arsenic-caused internal cancers, in particular bladder cancer and lung cancer (29). Average exposures were in the order of 500 µg/l (0.5 mg/l) over 1020 years; exposure decreased in subsequent years after remediation efforts were introduced (29) . Long latency was apparent, and increases in mortality continued for 40 years after the highest exposures began (29). In Argentina, a mortality study in the arsenic-exposed region of Córdoba found increased risks of bladder and lung cancer among men and women from 1986 to 1991, although concentrations were lower (average 178 µg/l) than in Taiwan and Chile (31, 32).
Using the current US Environmental Protection Agency standard of 50 µg/l, it has been estimated that the lifetime risk of dying from cancer of the liver, lung, kidney or bladder while drinking 1 litre a day of water containing arsenic at this concentration could be as high as 13 per 1000 persons exposed (30). Using the same methods, the risk estimate for 500 µg/l of arsenic in drinking-water would be 13 per 100 people (33). In its latest document on arsenic in drinking-water, the US National Research Council concluded that exposure to 50 µg/l could easily result in a combined cancer risk of 1 in 100 (34).
Although specific estimates of the current and future health effects of arsenic exposure are uncertain, in the case of Bangladesh it can be inferred that since there are many people who currently have skin lesions caused by ingesting arsenic, many more cases will occur if exposure continues; based on what is known about the relationship between ingestion and the development of internal cancers, it is reasonable to expect marked increases in mortality from internal cancers once sufficient latency has been reached. It is also reasonable to expect marked increases in the incidence of the other health effects listed in Box 2.
Classifying arsenic in drinking-water as a public health emergency
Classifying contamination of groundwater by arsenic as a public health emergency would facilitate the rapid allocation of funding and the prompt expansion of interventions. Issues central to the argument in favour of an emergency response are listed in Box 3.
Arsenic exposure may be mitigated in a relatively straightforward manner. However, in Bangladesh the situation is complicated by the weak economy and the need to rely largely on external aid to resolve public health problems. There are also significant difficulties in communication and transportation within the country that create obstacles for community education and intervention programmes. Nevertheless, in contrast to diseases like malaria, cholera and tuberculosis, which require a more complex public health response, the response to arsenic contamination is clear-cut: provide arsenic-free water. Although the precise extent of the problem is not known, this does not invalidate the need for an emergency response. The extent of the problem may be more accurately determined during the course of the response. The health of the population is at risk and relief cannot wait for further surveys.
Emergency intervention programme
The core activity of an emergency action plan for this threat to human health should be rapid case ascertainment and immediate provision of arsenic-free water. The objectives of such a plan should be as follows: (1) to identify all cases of arsenicosis in Bangladesh; (2) the immediate identification of an interim source of arsenic-free water and commencement of implementation of the long-term solution; (3) to monitor patients progress and compliance with interim water treatment until a long-term water source has been identified and made available; and (4) to provide care for patients, including vitamin supplementation, lotions for patients with keratoses and treatment of infections.
Strategies to reduce exposure
A short-term strategy might include five responses. Firstly, identify nearby tube-wells that have water with a low arsenic content. Secondly, provide a water filter for each household. A candle filtration system is available. It is easy to use and maintain, and this contributes to good compliance. The disadvantage is that the arsenic-loaded candles must be disposed of but this should not be a problem if the filter is used as an interim solution for a few months only. Units designed to be attached to tube-wells to remove arsenic are being tested and may prove to be an effective short-term alternative. Thirdly, provide chemicals to be used daily to remove arsenic from household drinking-water. The small packet of chemicals that can be mixed in water and left to stand overnight is very cheap and is simple to transport. The disadvantages of this strategy include the need for daily or close to daily use and the need to dispose of the sludge after each treatment. Whether people will use these chemicals needs to be evaluated. Fourthly, use surface water sources that have been treated by filtration and chlorination. Fifthly, close highly contaminated wells when a temporary water source has been identified.
Field kits should be used if they can detect contamination of water containing 100 µg/l or more of arsenic. It would be better still if they could reliably detect 50 µg/l. Since WHOs recommended maximum concentration of 10 µg/l cannot be accurately measured with a field kit, it has been proposed that samples should be sent to laboratories for testing. However, sending samples to a laboratory can cause delays to programmes in the affected communities. In contrast, using field kits that can measure concentrations of 50 µg/l provides instantaneous results and facilitates prompt action to find an alternative water source if needed (35).
Some interventions that involve major actions, such as treating water with chemical packets, are inexpensive as far as materials are concerned but are expensive in terms of training, monitoring and education. Treating water with alum or allowing it to stand so that arsenic settles in iron-rich water is not advisable since reducing exposure in the short-term by the order of 50% (compared with a reduction of 8090%) does little to alter the cumulative dose on which arsenic disease risks are based, and it may delay the planning for an arsenic-free solution. For example, if a short-term intervention reduces arsenic concentrations in water by 50% for 2 years but in the process uses resources and reduces motivation, thus delaying the provision of arsenic-free water for 1 year, then there has been no health benefit from the resources used because there has been no reduction in the cumulative intake of arsenic.
Further work is needed in planning long-term intervention measures. For the moment, unless there are local contraindications, the sinking of deep tube-wells (below 200 m) and dug wells or ring-wells (2030 m) appear to be successful options. Deep tube-wells, however, have potential problems and must be installed carefully to avoid cross-contamination from shallower aquifers. Another potential long-term solution, rain-water harvesting, also warrants attention because of the high annual rainfall in the region. However, in our view, arsenic removal treatment systems have serious problems with maintenance and the disposal of arsenic sludge, and cannot be recommended as long-term solutions.
Relief from continuing arsenic ingestion cannot wait until the necessary investigations are completed for the long-term planning of alternative water sources. From a public health standpoint, emergency interventions are best accomplished through an existing technology which has already been tested and is known to be well received at the population level. Interventions requiring adjustments to an existing behaviour (for example, using a different tube-well that is a little further away) are generally more effective than introducing interventions of a new or unfamiliar nature (for example, using chemical packets to treat household water or harvesting rain water during part of the year and using another source for the rest of the year). This is particularly true in the case of arsenic poisoning because people might find it difficult to believe that crystal clear water is responsible for disease and death. The use of alternative, non-contaminated, shallow tube-wells, and the insertion of dug wells or sinking of deep tube-wells where there are no uncontaminated shallow wells, would appear to be the interventions that best satisfy these two criteria for an emergency programme.
Simple diagnosis in the field
The diagnosis of disease caused by chronic ingestion of inorganic arsenic is usually straightforward. The most common signs are hyperpigmentation, especially on the upper chest and arms, and keratoses on the palms and soles of the feet (Fig. 1). Keratoses on the palms of hands and soles of the feet are very characteristic (except in very mild early cases). The diagnosis is confirmed if a patient with keratoses and hyperpigmentation is found to have been drinking water with a high arsenic content over a period of years.
The diagnosis of arsenic-caused disease is facilitated by the ability to rapidly assess concentrations of arsenic in water. The ideal test would be one that could be done immediately in the field. Since the purpose of such tests is to detect significant exposure, the methods used do not need to be able to detect low concentrations nor do they need to have high precision. For diagnostic purposes, it would be sufficient to detect concentrations greater than 50 µg/l or 100 µg/l. At the high concentrations often encountered in Bangladesh, precision could be relatively low. For example, if a true water concentration were 350 µg/l, for initial diagnostic purposes it would be sufficient to know that the concentration was in the range 200600 µg/l. A field kit that uses locally made materials, which was designed by the National Institute of Preventive and Social Medicine in Bangladesh, has received good evaluations in a programme sponsored by WHO (5).
High accuracy and precision in water measurements make little sense when human exposure also depends on the volume of water ingested. Even with careful interviewing for 10 to 15 minutes, the volume of water ingested from a particular source over the years can only be estimated within broad ranges. If a patient drank about 24 l of arsenic-contaminated water per day over the past 10 years, it is clear that the current concentration of arsenic in his or her drinking-water does not have to be measured with a precision of + 5%.
Many other signs and symptoms have been reported in those patients who have chronically ingested arsenic. In studies in West Bengal, respiratory symptoms, crepitations and liver enlargement are prevalent (36, 37). However, these signs are non-specific and are typically accompanied by hyperpigmentation or keratoses, or both.
Since the diagnosis of arsenicosis can usually be established by simple examination of the skin, there is no need for expensive tests or for the typical patient, who may be free from other complications, to be admitted to hospital. Examination of the patient in the field, supplemented with an analysis of the arsenic content of water samples, can suffice. The examination for skin lesions itself does not require special skills or medical training.
At very high concentrations, acute symptoms may occur long before skin lesions appear. The most common early symptoms are gastrointestinal, including diarrhoea and abdominal pain (10). Peripheral neuropathy may occur. Such non-specific signs and symptoms in a patient living in an arsenic-exposed region should alert the physician or nurse to investigate the sources of drinking-water.
Skin cancer caused by arsenic is usually accompanied by non-malignant skin effects. The internal cancers caused by arsenic have no special features and no special diagnostic procedures can be used.
The basic treatment is to supply the patient with drinking-water that is free from arsenic. This is the first priority. Indeed, in the absence of good evidence for the effectiveness of other treatments, the second priority is to continue providing arsenic-free water, and the third priority is to monitor patients to ensure that they remain unexposed to arsenic. Providing arsenic-free water reduces the risk of further complications and disease caused by arsenic. There are no well-designed studies to show whether
cessation of exposure leads to improvement in skin keratoses. Thus far, anecdotal interviews of patients suggests that mild to moderate keratoses do improve with cessation of exposure.
Chelation. Some physicians have been giving chelation therapy to arsenic patients in West Bengal and Bangladesh. The objective of chelation therapy is to provide the patient with a chemical to which arsenic binds strongly, and is then excreted in urine. Providing such treatment could remove large stores of arsenic from the body in a matter of hours.
There are several problems with chelation therapy in cases of chronic arsenic exposure. The first is related to the observation that arsenic is excreted rapidly even without chelation therapy. Most of the readily available arsenic in the body will be excreted in the urine within 1 week (38, 39). The question is whether chelation might remove arsenic which is, for example, bound in the skin and which might without chelation only be removed slowly. This is possible but exposure to arsenic generally occurs over many years, and chelation may make little difference to the cumulative dose of arsenic that patients have received. Thus, chelation therapy is unlikely to reduce the future risk of cancer. Whether it might improve keratoses more rapidly than simply stopping exposure is unknown. This idea has some plausibility but its effectiveness has not been established.
The second problem with chelation therapy is the lack of any clinical trials that found evidence of its effectiveness (40). When exposure to arsenic ceases, improvement in skin lesions might occur. Thus, if a patient improves after chelation therapy it could be due to the cessation of exposure alone or to both cessation and chelation therapy. Finding that patients improve after chelation therapy does not provide evidence that the therapy itself is effective.
The third problem with chelation therapy is that it is of no benefit if the patient continues to drink contaminated water after treatment, and it may give the false impression that effects can be treated despite continued exposure. Thus, chelation therapy should not be used routinely, although careful controlled studies of chelation therapy in patients with keratoses and other arsenic effects should perhaps be undertaken.
Nutrition. Since evidence from Taiwan suggests that some nutritional factors may modify cancer risks associated with arsenic (41), it has been proposed that providing vitamins and improving nutrition may be of benefit to patients. In particular, vitamin A is known to be beneficial in the differentiation of various tissues, particularly the skin. If the doses given are not excessive, there are other nutritional benefits to providing vitamins, particularly in populations that may have inadequate levels of micronutrients. For these reasons, it is recommended that all patients with skin lesions be provided multivitamin tablets and that research projects be undertaken to establish whether or not they are effective for patients with arsenicosis.
Other considerations. Advanced keratoses on the palms of the hands and soles of the feet are extremely debilitating, and superimposed infections, such as fungal infections, may cause serious problems. Providing moisturizing lotions and treatment for infections may be beneficial and should be part of routine care in advanced cases. These topics should be systematically studied. Arsenic is a probable contributor to causation of diabetes mellitus (42, 43). For this reason, urinary glucose should be tested in all patients with arsenicosis, and appropriate treatment and monitoring should be started if necessary. Patients blood pressure should also be monitored since arsenic exposure may induce hypertension (44).
Despite some attempts to educate communities, large numbers of people continue to drink from the same contaminated water sources used before the introduction of an intervention. Other water testing programmes carried out with the aid of community health workers have indicated that community awareness increases as a consequence of the programmes (45). Therefore, continuing education and monitoring needs to be integrated into existing health services, whether governmental or nongovernmental.
Guidelines for programmes aimed at continuing to educate and monitor populations exposed to arsenic should include advising these populations about the arsenic in drinking-water, the sources of arsenic-free water, and the importance of compliance with treatment programmes, including nutrition. Field workers should make monthly home visits to those villages that are most seriously affected. Field workers should be equipped with a continuing education plan, topical creams for keratoses, vitamin tablets, and medicines for fungal infections.
Patients should be advised where to seek additional medical care if needed. The physicians and paramedical staff serving the most affected areas should receive special training in understanding arsenic toxicity, disease outcomes and treatment options.
The possibility of continuing exposure to arsenic through water or food should be monitored through the testing of urine samples. Currently, there is no recommended field kit for urine testing. Therefore, samples should be sent to a reference laboratory equipped to measure arsenic in biological specimens.
In addition to obtaining biological samples, field workers should interview patients and ask them where they currently get their drinking-water to assess whether they are complying with the intervention or whether they are continuing to put their health at risk by drinking contaminated water. These regular interviews will provide opportunities for ongoing health education.
Lessons to be learned
The discovery of arsenic contamination of groundwater in many nations, including Argentina, Chile, China, India, Mexico, Taiwan, Thailand, the United States and, now, Bangladesh shows that this is a global problem. All groundwater sources used for drinking-water should be tested for arsenic. A retrospective look at the situation in Bangladesh is instructive in that a declaration of a public health emergency might have expedited a more rapid response to the problem. In the three years after the original consultancy in Bangladesh for WHO (35), the rapid intervention team has only reached a few hundred villages. Millions of wells and people remain to be tested and examined. This experience in Bangladesh has reinforced the importance of using organizations and systems that are already in place in the affected area. When a rapid response to a health emergency is needed, it is not the time to reorganize or implement completely new systems. Rather, it is the time to take advantage of existing governmental and nongovernmental organizations, which already have contacts in the field and can thus respond quickly. The rapidity of the response is crucial the longer the exposure continues, the greater the likelihood of disease.
Contamination of drinking-water with arsenic further illustrates the difficulties of community-based interventions. It is likely that a single visit to a village, during which the water is tested and the nearest well painted red, will not have a long-term impact on the behaviour of members of the community, particularly if none of the villagers has any signs of arsenic-caused disease. Habits are difficult to break; one visit will not be convincing when the villagers look at the clear, clean water. Follow-up monitoring and education are integral to sustaining the impact of the first intervention and to safeguarding the populations health.
Most importantly, the arsenic contamination of groundwater in Bangladesh has indicated that delaying action in an attempt to be thorough in research and long-term planning can be a mistake. Long-term solutions will likely have to be tailored to local environments, and it is counterproductive to defer immediate action until the long-term alternatives are completely designed. The cause of arsenicosis is clear and continuing exposure increases the risk of non-fatal outcomes and death; these diseases can be eradicated at relatively low cost. In such a situation, the worst thing that can possibly be done is nothing.
Support for this work came from US Environmental Protection Agency grant no. R-826137-01-0, US National Institutes of Health grants P42ES04705 and P30ES01896, and the Center for Occupational and Environmental Health, University of California, Berkeley. Support for consultancy work came from the Bangladesh office of the World Health Organization.
1. Khan AW et al. Arsenic contamination in groundwater and its effect on human health with particular reference to Bangladesh. Journal of Preventive and Social Medicine, 1997, 16 (1): 6573.
2. Dhar RK et al. Groundwater arsenic contamination and sufferings of people in Bangladesh may be the biggest arsenic calamity in the world. Paper presented at the International Conference on Arsenic Pollution of Groundwater in Bangladesh: Causes, Effects and Remedies, Dhaka, Bangladesh, 812 February 1998.
3. Smith AH. Report and action plan for arsenic in drinking water focusing on health, Bangladesh. Assignment Report, WHO Project BAN CWS 001, March 1997 (available on the Internet at http://socrates.berkeley.edu/~asrg/).
4. Smith AH. Technical report and review of action plan for arsenic in drinking water in Bangladesh focusing on health. Assignment Report, WHO Project BAN CWS 001/D, February 1998 (available on the Internet at http://socrates. berkeley.edu/~asrg/).
5. Smith AH. Technical report. Assignment Report, WHO Project BAN CWS 001, June 1998 (available on the Internet at http://socrates.berkeley.edu/~asrg/).
6. Saha KC. Chronic arsenical dermatoses from tube-well water in West Bengal during 198387. Indian Journal of Dermatology, 1995, 40: 112.
7. Arsenic mitigation in Bangladesh. United Nations Childrens Fund (UNICEF), 1999 (Internet communication, 14 December 1999, available at http://www.unicef.org/arsenic).
8. UNICEF. Progotir pathey, on the road to progress; achieving the goals for children in Bangladesh, October 1998. Dhaka, Bangladesh Bureau of Statistics, Ministry of Planning, Government of the Peoples Republic of Bangladesh with UNICEF, 1998.
9. Country situation report: arsenic in drinking water in Bangladesh, 1996: a challenge in near future. Geneva, World Health Organization, 1996 (unpublished document).
10. WHO guidelines for drinking-water quality. Vol 2, 2nd ed. Geneva, World Health Organization, 1996.
11. Dhar RK et al. Groundwater arsenic calamity in Bangladesh. Current Science, 1997, 73: 4859.
12. Ahmad SA et al. Arsenic contamination in ground water and arsenicosis in Bangladesh. International Journal of Environmental Health Research, 1997, 7: 271276.
13. Biswas BK et al. Detailed study report of Samta, one of the arsenic-affected villages of Jessore District, Bangladesh. Current Science, 1998, 74: 134145.
14. Executive summary of the main report of Phase I, groundwater studies of arsenic contamination in Bangladesh. British Geological Survey and Mott MacDonald (UK) for the Government of Bangladesh, Ministry of Local Government, Rural Development and Cooperatives, Department of Public Health Engineering, and Department of International Development (UK), 1999 (Internet communication, 15 December 1999, available at http://www.damient-consul.co.jp/english/arsenic/article/ DFID-sum.html).
15. Chowdhury TR et al. Arsenic poisoning in the Ganges delta. Nature, 1999, 401: 545546.
16. Quamruzzaman Q et al. Rapid action programme: emergency arsenic mitigation programme in two hundred villages in Bangladesh. In: Arsenic Exposure and Health Effects: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects, 1215 July 1998, San Diego. Oxford, Elsevier Science, 1999: 363366.
17. Biswas BK et al. Groundwater arsenic contamination and sufferings of people in Bangladesh, a report up to January 1999. Paper presented at the International Conference, Arsenic in Bangladesh Ground Water: Worlds Greatest Arsenic Calamity, Staten Island, New York, USA, 2728 February 1999.
18. The Bangladesh arsenic mitigation water supply project: addressing a massive public health crisis. The World Bank Group, October 1999 (Internet communication, 13 December 1999, available at http://wbln1018.worldbank.org/sar/sa.nsf).
19. Tondel M et al. The relationship of arsenic levels in drinking water and the prevalence of skin lesions in Bangladesh. Environmental Health Perspectives, 1999, 107: 727729.
20. Das D et al. Arsenic in groundwater in six districts of West Bengal, India. Environmental Geochemistry and Health, 1996, 18: 515.
21. Mandal BK et al. Arsenic in groundwater in seven districts of West Bengal, India the biggest arsenic calamity in the world. Current Science, 1996, 70: 976986.
22. Guha Mazumder DN et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. International Journal of Epidemiology, 1998, 27: 871877.
23. Milton AH, Rahman M. Environmental pollution and skin involvement pattern of chronic arsenicosis in Bangladesh. Journal of Occupational Health, 1999, 41: 207208.
24. Tseng WP et al. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. Journal of the National Cancer Institute, 1968, 40: 453463.
25. United States Environmental Protection Agency. Special report on ingested inorganic arsenic; skin cancer; nutritional essentiality Risk Assessment Forum. Washington, DC, Environmental Protection Agency, 1988 (publication no. EPA 625/3-87/013).
26. Chen CJ et al. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Research, 1985, 45: 58955899.
27. Chen CJ, Chen CW, Wu MM. Arsenic and cancer. Lancet, 1988, 1: 414415.
28. Chen CJ et al. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. British Journal of Cancer, 1992, 66: 888892.
29. Smith AH et al. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. American Journal of Epidemiology, 1998, 147: 660669.
30. Smith AH et al. Cancer risks from arsenic in drinking water. Environmental Health Perspectives, 1992, 97: 259257.
31. Hopenhayn-Rich C et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology, 1996, 7: 117124.
32. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. International Journal of Epidemiology, 1998, 27: 561569.
33. Smith AH et al. Cancer risks from arsenic in drinking water: implications for drinking water standards. In: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects, 1215 July 1998, San Diego. Oxford, Elsevier Science, 1999: 191200.
34. National Research Council. Arsenic in drinking water. Washington, DC, National Academy Press, 1999.
35. Final draft report: assessment of arsenic field testing kits. Nagpur, India, National Environmental Engineering Research Institute, 1998.
36. Chakraborty AK, Saha KC. Arsenical dermatosis from tubewell water in West Bengal. Indian Journal of Medical Research, 1987, 85: 326334.
37. Guha Mazumder DN et al. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. International Journal of Epidemiology, 2000, in press.
38. Mappers R. Experiments on excretion of arsenic in urine. International Archives of Occupational and Environmental Health, 1977, 40: 267272.
39. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. International Archives of Occupational and Environmental Health, 1981, 48: 111118.
40. Guha Mazumder DN et al. Randomized placebo-controlled trial of 2,3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water. Clinical Toxicology, 1998, 36: 683690.
41. Hsueh Y et al. Serum b-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiology, Biomarkers and Prevention, 1997, 6: 589596.
42. Rahman M et al. Diabetes mellitus associated with arsenic exposure in Bangladesh. American Journal of Epidemiology,1998, 148: 198203.
43. Rahman M et al. Relations between exposure to arsenic, skin lesions, and glucosuria. Occupational and Environmental Medicine, 1999, 56: 277281.
44. Rahman M et al. Hypertension and arsenic exposure in Bangladesh. Hypertension, 1999, 33: 7478.
45. Chowdhury M, Jakariya M. Testing of water for arsenic in Bangladesh. Science, 1999, 284: 1622.
Allan H. Smith
1140 Warren Hall, School of Public Health, University of California, Berkeley
Berkeley, CA 94720-7360, USA